#neoantigen — Monday, August 17, 2026 (1 items)
| 0 | ℹ |
A viral-based individualized neoantigen vaccine as adjuvant treatment in resected head and neck squamous cell carcinoma: a randomized Phase I trial.
(nature.com)
|
Nature Communications 2026-08-17 | #vaccination #immunotherapy #neoantigen #immunogenicity #carcinoma |